Skip to main content

Peer Review reports

From: Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer

Original Submission
5 Oct 2023 Submitted Original manuscript
28 Jan 2024 Reviewed Reviewer Report
2 Feb 2024 Reviewed Reviewer Report
7 Mar 2024 Author responded Author comments - Huayi Li
Resubmission - Version 2
7 Mar 2024 Submitted Manuscript version 2
14 Mar 2024 Reviewed Reviewer Report
27 Mar 2024 Reviewed Reviewer Report
20 Apr 2024 Author responded Author comments - Huayi Li
Resubmission - Version 3
20 Apr 2024 Submitted Manuscript version 3
25 Apr 2024 Author responded Author comments - Huayi Li
Resubmission - Version 4
25 Apr 2024 Submitted Manuscript version 4
Publishing
29 Apr 2024 Editorially accepted
16 May 2024 Article published 10.1186/s12916-024-03409-9

You can find further information about peer review here.

Back to article page